SHAPE-ENDO (Strategic Hormonal Approach & Prehabilitation in Endometrial Cancer): Prospective Observational Study for Metabolic and Surgical Optimization in Patients With Atypical Endometrial Hyperplasia or Early-stage Endometrial Cancer and BMI ≥35
Latest Information Update: 07 Apr 2026
At a glance
- Drugs Levonorgestrel (Primary) ; Semaglutide (Primary)
- Indications Endometrial hyperplasia; Obesity
- Focus Therapeutic Use
- Acronyms SHAPE-ENDO
Most Recent Events
- 13 Mar 2026 New trial record